You are here

GenMark Diagnostics Reports Fourth Quarter and Full Year 2018 Results

CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fourth quarter and year ended December 31, 2018.
Thursday, February 21, 2019 - 16:05